Corporate Banner
Satellite Banner
Cell Culture
Scientific Community
 
Become a Member | Sign in
Home>News>This Article
  News
Return

CYTOO’s 2D+ Cell Culture Platform Enables Quantitative Mapping

Published: Wednesday, September 19, 2012
Last Updated: Wednesday, September 19, 2012
Bookmark and Share
New applications represent a major step towards quantitative high content analysis of cellular organization in high throughput screening.

CYTOO S.A., has announced new results that demonstrate the ability of the Company’s 2D+ Cell Culture Platform to enable two new high content analysis (HCA) approaches: (i) quantitative density mapping of trafficking compartments and (ii) standardized mitochondrial analysis.

The results will be presented next week at MiPTec 2012 in Basel by the researchers from the Institut Curie in Paris and Angers University Hospital/INSERM, France.

The CYTOO 2D+ Cell Culture Platform, which was launched in July 2012, is based on the use of adhesive micropatterns in microplate wells to guide the cell architecture and behavior in culture.

By defining the 2D topology of cell adhesion, the 2D+ Technology enables the fine control of the spreading and 3D shape of cultured cells in single- or multi-cellular configurations resulting in control of cell contractility, cell polarity, organelle positioning, or cell division axis.

This opens new perspectives for more physiologically relevant cell-based assays compared to classical 2D culture where cells spread and move in an uncontrolled manner.

The researchers of Bruno Goud’s team at the Institut Curie will present at MipTec novel data showing the use of the 2D+ Cell Culture Platform to identify proteins that sustain steady-state organization of trafficking compartments by high-throughput density mapping in several compound and siRNA high content screens.

Following the method developed previously by the team, the hits were selected based on the P-value calculated from the difference between the density map of a pooled control and the density map of each treated condition in the screen.

The data from only 30 cells per condition was sufficient to get statistically significant results.

In comparison, “state-of-the-art” HCA using unrestricted cells with considerable cell-to-cell variation requires hundreds or thousands of cells in order to get significant results.

Arnaud Chevrollier from Angers University Hospital will present the use of the CYTOO 2D+ technology to standardize the quantification of mitochondrial networks in primary skin fibroblasts.

The increasing importance of defective mitochondrial dynamics in several diseases including common neurodegenerative disorders, cardiomyopathies, or age-related disorders, has called for the development of reference imaging tools for medical investigation and drug discovery.

However, until now current approaches to study complex mitochondrial morphology have been limited to low throughput analysis due to the ever varying shape and distribution of the mitochondrial network in cells with heterogeneous size and morphology that is inherent to culture conditions but has no direct biological significance.

The CYTOO 2D+ micropatterned arrays enabled standardization of the size and shape of the cells in culture allowing, for the first time, a high content quantitative relationship between the organization of the mitochondrial network and specific experimental and pathological conditions.

This novel approach can also be applied to high content screening to systematically identify compounds and pathways that impact mitochondrial abundance and sub-cellular distribution.

Commenting on the new results, Michel Bornens, Ph.D, CYTOO Chief Scientific Officer, said: “These two studies to be presented at MiPTec this year demonstrate how, 2D+ Cell Culture Platform enables completely new powerful high content analysis approaches that were previously impossible. We are delighted to see this new data, which represent a major step towards quantitative HCA of cellular organization in high throughput screens.”


Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,500+ scientific posters on ePosters
  • More than 3,700+ scientific videos on LabTube
  • 35 community eNewsletters


Sign In



Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into TechnologyNetworks.com you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.


Scientific News
Women’s Immune System Genes Operate Differently from Men’s
A new technology reveals that immune system genes switch on and off differently in women and men, and the source of that variation is not primarily in the DNA.
DNA Damage Seen in Patients Undergoing CT Scanning
Along with the burgeoning use of advanced medical imaging tests over the past decade have come rising public health concerns about possible links between low-dose radiation and cancer.
Yeast Cells Use Signaling Pathway to Modify Their Genomes
Researchers at the Babraham Institute and Cambridge Systems Biology Centre, University of Cambridge have shown that yeast can modify their genomes to take advantage of an excess of calories in the environment and attain optimal growth.
New Material Forges the Way for 'Stem Cell Factories'
Researchers have discovered the first fully synthetic substrate with potential to grow billions of stem cells. The researchcould forge the way for the creation of 'stem cell factories' - the mass production of human embryonic (pluripotent) stem cells.
New Measurements Reveal Differences Between Stem Cells for Treating Retinal Degeneration
By growing two types of stem cells in a “3-D culture” and measuring their ability to produce retinal cells, a team lead by St. Jude Children’s Research Hospital researchers has found one cell type to be better at producing retinal cells.
Researchers Identify Critical Genes Responsible for Brain Tumor Growth
After generating new brain tumor models scientists have identified the role of a family of genes underlying tumor growth in a wide spectrum of high grade brain tumors.
Growing Spinal Disc Tissue
Scientists develop new method for growing spinal disc tissue in the lab for combating chronic back pain.
A New Path Towards a Universal Flu Vaccine
New research suggests it may be possible to harness a previously unknown mechanism within the immune system to create more effective and efficient vaccines against this ever-mutating virus.
Potential New Class of Cancer Drugs
Scientists have found a way to stop cancer cell growth by targeting the Warburg Effect, a trait of cancer cell metabolism that scientists have been eager to exploit.
Human Trials of Manufactured Blood Within Two Years
The first human trials of lab-produced blood to help create better-matched blood for patients with complex blood conditions has been announced by NHS Blood and Transplant.
SELECTBIO

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,500+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!